Tilray Acquires HelloMD, Vertically Integrating Canadian Medical Cannabis
TLRY sits 17% above its 52-week low of $3.93.
Summary
Tilray Brands has acquired HelloMD, a digital healthcare and patient engagement platform, to expand its direct-to-patient capabilities and establish a fully vertically integrated medical cannabis framework in Canada. This strategic move aims to strengthen Tilray's global medical cannabis platform by enhancing patient access, education, and engagement. The acquisition follows recent positive developments for Tilray, including strong financial results and favorable regulatory shifts in the cannabis sector.
At the time of this announcement, TLRY was trading at $4.61 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $553.2M. The 52-week trading range was $3.93 to $23.20. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.